Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway

Figure 2

Correlation between S100A16 and clinical data of patients with RCC. p < 0.05, p < 0.01, p < 0.001.

(a)

(b)

(c)

(d)

(e)